These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 8690826)
1. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826 [TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients. Fabre L; Birkhimer LJ; Zaborny BA; Wong LF; Kapik BM Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649 [TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735 [TBL] [Abstract][Full Text] [Related]
4. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine. Kasper S; Möller HJ; Montgomery SA; Zondag E Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821 [TBL] [Abstract][Full Text] [Related]
6. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder. Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622 [TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464 [TBL] [Abstract][Full Text] [Related]
9. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358 [TBL] [Abstract][Full Text] [Related]
10. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Gonella G; Baignoli G; Ecari U Curr Med Res Opin; 1990; 12(3):177-84. PubMed ID: 2125547 [TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression. Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition]. Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991 [TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study. Ottevanger EA Encephale; 1995; 21(4):317-21. PubMed ID: 7588171 [TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663 [TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. Feighner JP; Boyer WF; Meredith CH; Hendrickson GG Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630 [TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560 [TBL] [Abstract][Full Text] [Related]
18. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. Versiani M; Amrein R; Stabl M Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378 [TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. Kiev A; Feiger A J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424 [TBL] [Abstract][Full Text] [Related]
20. Buspirone and imipramine for the treatment of major depression in the elderly. Schweizer E; Rickels K; Hassman H; Garcia-España F J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]